DZ3180A1 - Produits de médicaments à base de beta-carboline. - Google Patents

Produits de médicaments à base de beta-carboline.

Info

Publication number
DZ3180A1
DZ3180A1 DZ003180A DZ003180A DZ3180A1 DZ 3180 A1 DZ3180 A1 DZ 3180A1 DZ 003180 A DZ003180 A DZ 003180A DZ 003180 A DZ003180 A DZ 003180A DZ 3180 A1 DZ3180 A1 DZ 3180A1
Authority
DZ
Algeria
Prior art keywords
carboline
beta
products based
drug products
drug
Prior art date
Application number
DZ003180A
Other languages
English (en)
French (fr)
Inventor
Neil R Anderson
Kerry J Hartauer
Martha A Kral
Gregory A Stephenson
Original Assignee
Lilly Icos Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22520112&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DZ3180(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Icos Llc filed Critical Lilly Icos Llc
Application granted granted Critical
Publication of DZ3180A1 publication Critical patent/DZ3180A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DZ003180A 1999-08-03 2000-08-01 Produits de médicaments à base de beta-carboline. DZ3180A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14704899P 1999-08-03 1999-08-03
PCT/US2000/020981 WO2001008688A2 (en) 1999-08-03 2000-08-01 Beta-carboline drug products

Publications (1)

Publication Number Publication Date
DZ3180A1 true DZ3180A1 (fr) 2001-02-08

Family

ID=22520112

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ003180A DZ3180A1 (fr) 1999-08-03 2000-08-01 Produits de médicaments à base de beta-carboline.

Country Status (33)

Country Link
EP (1) EP1200092B1 (pt)
JP (1) JP4456788B2 (pt)
KR (1) KR20020063842A (pt)
CN (2) CN1377270A (pt)
AR (1) AR033953A1 (pt)
AT (1) ATE264680T1 (pt)
AU (1) AU773666B2 (pt)
BR (1) BR0012901A (pt)
CA (1) CA2380087C (pt)
CO (1) CO5200849A1 (pt)
CZ (1) CZ300151B6 (pt)
DE (1) DE60010089T2 (pt)
DK (1) DK1200092T3 (pt)
DZ (1) DZ3180A1 (pt)
EA (1) EA004302B9 (pt)
ES (1) ES2220506T3 (pt)
HK (1) HK1044278B (pt)
HR (1) HRP20020091B1 (pt)
HU (1) HU229443B1 (pt)
IL (1) IL147642A0 (pt)
MX (1) MXPA02001197A (pt)
MY (1) MY125428A (pt)
NO (1) NO321602B1 (pt)
NZ (1) NZ516613A (pt)
PE (1) PE20010480A1 (pt)
PL (1) PL199469B1 (pt)
PT (1) PT1200092E (pt)
SK (1) SK286365B6 (pt)
SV (1) SV2002000137A (pt)
TW (1) TWI235658B (pt)
UA (1) UA71629C2 (pt)
WO (1) WO2001008688A2 (pt)
ZA (1) ZA200200825B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2435816T3 (es) * 1999-08-03 2013-12-23 Icos Corporation Formulación farmacéutica que comprende una Beta-carbolina y su uso para el tratamiento de la disfunción sexual
EP2216329A1 (en) * 2004-10-28 2010-08-11 Dr. Reddy's Laboratories Ltd. Processes for the preparation of tadalafi
CA2627693A1 (en) * 2006-01-05 2007-07-19 Teva Pharmaceutical Industries Ltd. Wet granulation pharmaceutical compositions of aripiprazole
DE102007028869A1 (de) 2007-06-22 2008-12-24 Ratiopharm Gmbh Verfahren zur Herstellung eines Arzneimittels enthaltend Tadalafil
MD4009C2 (ro) * 2008-07-15 2010-08-31 Институт Химии Академии Наук Молдовы Utilizarea 1-metil-4-(N-metilaminobutil-4)-β-carbolinei în calitate de remediu antituberculos
DE102009033396A1 (de) 2009-07-16 2011-01-20 Ratiopharm Gmbh Wässrige Lösung und gelatinierte Zusammensetzung umfassend einen Phosphodiesterase-5-Inhibitor sowie diesbezügliche Verfahren und Verwendung
DE102009035211A1 (de) 2009-07-29 2011-02-17 Ratiopharm Gmbh Copräzipitate umfassend einen Phosphodiesterase-5-Inhibitor (PDE-5-Inhibitor) und einen pharmazeutisch verträglichen Trägerstoff, ihre Herstellung und Verwendung
WO2012085927A2 (en) * 2010-12-02 2012-06-28 Mylan Laboratories, Limited Tadalafil compositions
WO2012095151A1 (en) 2010-12-23 2012-07-19 Zaklady Farmaceutyczne Polpharma Sa Solid pharmaceutical dosage forms comprising tadalafil and methods of preparation thereof
EP2672959A1 (en) 2011-02-10 2013-12-18 Synthon BV Granulated composition comprising tadalafil and a disintegrant
WO2012107092A1 (en) 2011-02-10 2012-08-16 Synthon Bv Pharmaceutical composition comprising tadalafil and a cyclodextrin
WO2012107541A1 (en) 2011-02-10 2012-08-16 Synthon Bv Pharmaceutical composition comprising tadalafil and a cyclodextrin
JP5930686B2 (ja) * 2011-12-07 2016-06-08 株式会社トクヤマ 溶解性および安定性の向上した難溶性医薬品原体及びその製造方法
KR102268695B1 (ko) 2012-03-15 2021-06-23 메르크 파텐트 게엠베하 전자 소자
WO2014003677A1 (en) * 2012-06-28 2014-01-03 Xspray Microparticles Ab Pharmaceutical compositions comprising solid dispersion particles containing tadalafil
WO2014003678A1 (en) * 2012-06-28 2014-01-03 Xspray Microparticles Ab Pharmaceutical compositions comprising ambrisentan and solid dispersion particles containing tadalafil
CN105310984A (zh) * 2014-06-10 2016-02-10 合肥贝霓医药科技有限公司 一种pde5抑制剂的超微粉体及其制备方法
KR101562197B1 (ko) * 2014-06-24 2015-10-23 (주)우신메딕스 타다라필을 함유하는 구강 붕해형 필름 제제 및 이의 제조방법
EP3172207B1 (en) 2014-07-23 2019-03-06 KRKA, d.d., Novo mesto A process for the preparation of cgmp-phosphodiesterase inhibitor and oral pharmaceutical formulation comprising tadalafil co-precipitates
JP2016106139A (ja) * 2016-03-07 2016-06-16 株式会社トクヤマ 溶解性および安定性の向上した難溶性医薬品原体及びその製造方法
AU2018397436A1 (en) * 2017-12-26 2020-08-13 Ftf Pharma Private Limited Liquid oral formulations for PDE V inhibitors
LT3510997T (lt) 2018-01-10 2021-01-11 Gap S.A. Minkšta želatinos kapsulė, apimanti tadalafilio suspensiją
CN110638770B (zh) * 2019-10-25 2022-04-05 株洲千金药业股份有限公司 他达拉非片剂的制备方法及以该方法制得的片剂
WO2023227185A1 (en) 2022-05-27 2023-11-30 Rontis Hellas S.A. Improved pharmaceutical composition containing tadalafil and nanomilling process for the preparation thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618845A (en) * 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
GB9511220D0 (en) * 1995-06-02 1995-07-26 Glaxo Group Ltd Solid dispersions

Also Published As

Publication number Publication date
EP1200092A2 (en) 2002-05-02
JP4456788B2 (ja) 2010-04-28
HK1044278B (zh) 2004-10-08
EA004302B9 (ru) 2019-01-31
PL199469B1 (pl) 2008-09-30
HRP20020091A2 (en) 2004-02-29
HRP20020091B1 (en) 2006-02-28
PT1200092E (pt) 2004-07-30
EA004302B1 (ru) 2004-02-26
SV2002000137A (es) 2002-06-07
WO2001008688A3 (en) 2001-08-16
IL147642A0 (en) 2002-08-14
CZ2002387A3 (cs) 2002-10-16
NO20020531D0 (no) 2002-02-01
HK1044278A1 (en) 2002-10-18
MXPA02001197A (es) 2003-02-12
WO2001008688A2 (en) 2001-02-08
AU6508400A (en) 2001-02-19
PE20010480A1 (es) 2001-05-26
PL353268A1 (en) 2003-11-03
SK1722002A3 (en) 2002-05-09
EA200200119A1 (ru) 2002-06-27
HU229443B1 (en) 2013-12-30
BR0012901A (pt) 2002-04-16
CO5200849A1 (es) 2002-09-27
NO321602B1 (no) 2006-06-12
KR20020063842A (ko) 2002-08-05
ATE264680T1 (de) 2004-05-15
MY125428A (en) 2006-07-31
UA71629C2 (en) 2004-12-15
HUP0202781A2 (hu) 2002-12-28
HUP0202781A3 (en) 2003-10-28
NZ516613A (en) 2003-08-29
NO20020531L (no) 2002-04-03
ES2220506T3 (es) 2004-12-16
DE60010089D1 (de) 2004-05-27
AR033953A1 (es) 2004-01-21
CN101134019A (zh) 2008-03-05
CA2380087A1 (en) 2001-02-08
EP1200092B1 (en) 2004-04-21
CA2380087C (en) 2007-05-01
CZ300151B6 (cs) 2009-02-25
TWI235658B (en) 2005-07-11
JP2003505510A (ja) 2003-02-12
CN1377270A (zh) 2002-10-30
AU773666B2 (en) 2004-06-03
DK1200092T3 (da) 2004-08-16
DE60010089T2 (de) 2004-10-14
ZA200200825B (en) 2003-04-30
SK286365B6 (sk) 2008-08-05

Similar Documents

Publication Publication Date Title
DZ3180A1 (fr) Produits de médicaments à base de beta-carboline.
MXPA03006884A (es) Formulacion farmaceutica.
IT1307266B1 (it) Apparecchio per infusione di farmaci.
ITTO20010005A1 (it) Formulazione farmaceutica.
TR199901077A3 (tr) Ispençiyari formülasyonlar.
MXPA03007641A (es) Formulacion farmaceutica.
MXPA03007215A (es) Formulaciones farmaceuticas.
DE122010000009I2 (de) Beta2-adrenoceptor agonisten.
AP2004003055A0 (en) Platinum derivative pharmaceutical formulations.
ES1042687Y (es) Dispositivo dispensador de articulos aplanados.
TR199800631A3 (tr) Ecza formülasyonu.
PT1173434E (pt) Novo produto farmaceutico
DK1275397T3 (da) Lægemiddel til lokal anvendelse
NO20022606D0 (no) Farmasöytiske kombinasjoner
IT1311921B1 (it) Composti farmaceutici.
IT1313579B1 (it) Composizione farmaceutica liquida a base di paracetamolo.
BR0006105B1 (pt) produto à base de borracha.
IS6163A (is) Lyfjakomplex
AR025867A1 (es) Formulacion portasdora farmaceutica
DZ2159A1 (fr) Produits pharmaceutiques.
ATA173599A (de) Pharmazeutisches produkt
ZA200402731B (en) Pharmaceutical formulation.
IT1307258B1 (it) Apparecchio per infusione prolungata di farmaci.
ITBO990008A0 (it) Convogliatore .
IT249899Y1 (it) Espositore perfezionato di gioielli, particolarmente per vetrine.